← Leaderboards
Gary W Varilek
University Of Kentucky
$553,225
Attributed
$553,225
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$553,225 · 6
By mechanism
M01$373,242 · 4
K08$107,483 · 1
R03$72,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Bernhard Hennig$8,918,317
- Helieh S Oz$707,060
- Ching-Shih Chen$8,095,534
- Daret K St Clair$20,807,410
- Daniell B Hill$2,022,940
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationHuman SubjectClinical ResearchGastrointestinal Disorder ChemotherapyCrohn'S DiseaseDrug Screening /EvaluationTumor Necrosis Factor AlphaImmunotherapyOutcomes ResearchAntiantibodyAntiinflammatory AgentsLongitudinal Human StudyCell Adhesion MoleculesHeparinUlcerative ColitisClinical TrialsInflammatory Bowel DiseasesNuclear Factor Kappa BetaLaboratory MouseVitamin TherapyCytokine ReceptorsDisease /Disorder ModelFlavonoidsGene Induction /Repression
Grant awards (12)
TO EVALUATE SAFETY &EFFICACY OF ISIS 2303 IN STEROID DEPD CROHNS DISEASE$73,467
M01 · FY2002 · RR
HEPARIN IN TREATMENT OF ULCERATIVE COLITIS$73,467
M01 · FY2002 · RR
ANTI TNF ANTIBODY--LONG TERM THERAPY OF CROHN'S DISEASE$0
M01 · FY2002 · RR
TO EVALUATE SAFETY &EFFICACY OF ISIS 2303 IN STEROID DEPD CROHNS DISEASE$73,467
M01 · FY2001 · RR
HEPARIN IN TREATMENT OF ULCERATIVE COLITIS$73,467
M01 · FY2001 · RR
ANTI TNF ANTIBODY--LONG TERM THERAPY OF CROHN'S DISEASE$0
M01 · FY2001 · RR
CYTOKINE MODULATION OF INFLAMMATORY BOWEL DISEASE$107,483
K08 · FY2000 · DK
GREEN TEA AND INFLAMMATORY BOWEL DISEASE$72,500
R03 · FY2000 · DK
ANTI TNF CHIMERIC MOAB (CA2) IN TREATMENT OF PTS W/ CROHNS$26,458
M01 · FY2000 · RR
HEPARIN IN TREATMENT OF ULCERATIVE COLITIS$26,458
M01 · FY2000 · RR
TO EVALUATE SAFETY &EFFICACY OF ISIS 2303 IN STEROID DEPD CROHNS DISEASE$26,458
M01 · FY2000 · RR
ANTI TNF ANTIBODY--LONG TERM THERAPY OF CROHN'S DISEASE$0
M01 · FY2000 · RR